Cannasouth Limited (NZX: CBD, Cannasouth), today released its Annual Report for the year ended 31 December 2021.
Changes versus 2021 Unaudited Preliminary Results
On 1 March 2022 Cannasouth released to the market its preliminary results for the year ended 31 December 2021 (Preliminary Results). The table in the attached '2021 Annual Report Announcement' document summarises the key results.
The Preliminary Results were prepared on the basis that the accounting treatment for the acquisition of Midwest Pharmaceutics NZ Ltd and Cannasouth Cultivation Ltd was subject to audit. The reclassification of pre-acquisition transactions has no cash flow impacts.
Included with this announcement are the following documents:
• 2021 Annual Report
• Revised Results Announcement Form
-ENDS-
For further information visit www.cannasouth.co.nz or contact:
Mark Lucas
CEO
Email: [email protected]
Mobile: 021 484 649
Colin Foster
CFO / Company Secretary
Email: [email protected]
Mobile: 027 577 1498
The S&P/NZX 50 Index is down 1.5% since the beginning of the year.
Pacific Edge is on a trading halt until Monday.
The downgrade comes ahead of Jan 26, when Briscoe's financial year ends.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details